Actively Recruiting
Monitoring and Identifying Mild Traumatic Brain Injury Using the Rebion Eye Scan Device in Adults Aged 18 to 45
Led by Rebiscan, Inc. · Updated on 2026-05-20
60
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the Rebion trauma tool, called the Head and Intraocular Trauma Tool HITT, to detect changes in eye movements related to mild traumatic brain injury mTBI. The study aims to assess how well this binocular retinal scan device can identify disruptions in ocular fixation, alignment, and saccades caused by brain injury. The trial will include 60 patients with mTBI and 20 uninjured control participants. Participants will be divided into two groups controls without head trauma and TBI-suspected patients presenting with head trauma. The device will scan participants eyes up to three times, each scan lasting about 45 seconds, where they place their chin on a rest and focus on a light. Testing will occur at three time points at enrollment Day 0, Day 14, and Day 30 to monitor changes over time. During the study, participants will undergo retinal scanning sessions and simple examinations to assess eye movement. Researchers will measure the devices ability to detect brain injury on Day 1 and monitor eye movement changes on Days 14 and 30. Participants must be able to follow instructions and communicate in English or Spanish. The study will last about one month per participant, with multiple assessments to track progress and safety.
CONDITIONS
Brief Title
mTBI Identification and Monitoring Through Retinal Scanning
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here